Gene · 2175
Papers3,803
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,641 to 1,660 of 3,803
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Disease modeling and stem cell immunoengineering in regenerative medicine using CRISPR/Cas9 systems. | Comput Struct Biotechnol J | 2020 | 33304462 | PubTator, text mining | PubMed |
| Novel Pathogenic Germline Variant of the Adenomatous Polyposis Coli (APC) Gene, p.S2627Gfs*12 Identified in a Mild Phenotype of APC-Associated Polyposis: A Case Report. | Am J Case Rep | 2020 | 33303731 | PubTator, text mining | PubMed |
| Evolving insights: how DNA repair pathways impact cancer evolution. | Cancer Biol Med | 2020 | 33299637 | PubTator, text mining | PubMed |
| Clinicopathological and Molecular Characteristics of Pleomorphic Invasive Lobular Carcinoma. | Int J Breast Cancer | 2020 | 33299611 | PubTator, text mining | PubMed |
| Analysis of cesarean section rates using Robson ten group classification system in a tertiary teaching hospital, Addis Ababa, Ethiopia: a cross-sectional study. | BMC Pregnancy Childbirth | 2020 | 33298012 | PubTator, text mining | PubMed |
| Hepatic transcriptome and DNA methylation patterns following perinatal and chronic BPS exposure in male mice. | BMC Genomics | 2020 | 33297965 | PubTator, text mining | PubMed |
| Envelope-Specific Adaptive Immunity following Transplantation of Hematopoietic Stem Cells Modified with VSV-G Lentivirus. | Mol Ther Methods Clin Dev | 2020 | 33294492 | PubTator, text mining | PubMed |
| Glycosylation in Indolent, Significant and Aggressive Prostate Cancer by Automated High-Throughput N-Glycan Profiling. | Int J Mol Sci | 2020 | 33287410 | PubTator, text mining | PubMed |
| Multi-Mycotoxin Occurrence in Dairy Cattle and Poultry Feeds and Feed Ingredients from Machakos Town, Kenya. | Toxins (Basel) | 2020 | 33287105 | PubTator, text mining | PubMed |
| TTK, CDC25A, and ESPL1 as Prognostic Biomarkers for Endometrial Cancer. | Biomed Res Int | 2020 | 33282948 | PubTator, text mining | PubMed |
| The complex relationship between MITF and the immune system: a Melanoma ImmunoTherapy (response) Factor? | Mol Cancer | 2020 | 33276788 | PubTator, text mining | PubMed |
| Common germline-somatic variant interactions in advanced urothelial cancer. | Nat Commun | 2020 | 33273457 | PubTator, text mining | PubMed |
| Liquid biopsy for patients with IBD-associated neoplasia. | BMC Cancer | 2020 | 33272240 | PubTator, text mining | PubMed |
| Pituitary stalk interruption syndrome is characterized by genetic heterogeneity. | PLoS One | 2020 | 33270637 | PubTator, text mining | PubMed |
| Orientation processing by synaptic integration across first-order tactile neurons. | PLoS Comput Biol | 2020 | 33264287 | PubTator, text mining | PubMed |
| Pathogenic Germline Mutations of DNA Repair Pathway Components in Early-Onset Sporadic Colorectal Polyp and Cancer Patients. | Cancers (Basel) | 2020 | 33260537 | PubTator, text mining | PubMed |
| Genomic and transcriptomic alterations associated with drug vulnerabilities and prognosis in adenocarcinoma at the gastroesophageal junction. | Nat Commun | 2020 | 33257699 | PubTator, text mining | PubMed |
The absence of (TCAGGG)n repeats in some telomeres, combined with variable responses to NR2F2 depletion, suggest that this nuclear receptor plays an indirect role in the alternative lengthening of telomeres. | Sci Rep | 2020 | 33244044 | PubTator, text mining | PubMed |
| Therapeutic Potential of PARP Inhibitors in the Treatment of Metastatic Castration-Resistant Prostate Cancer. | Cancers (Basel) | 2020 | 33233320 | PubTator, text mining | PubMed |
| New insight into the significance of KLF4 PARylation in genome stability, carcinogenesis, and therapy. | EMBO Mol Med | 2020 | 33231937 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2175/papers?page=83